Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRME Prime Medicine, Inc.

休市中 11-15 16:00:00 EST

3.35

-0.25

-6.95%

盘后3.40

+0.05+1.64%

19:41 EST

最高3.61	最低3.30	成交量140.20万
今开3.61	昨收3.60	日振幅8.62%
总市值4.27亿	流通市值1.77亿	总股本1.28亿
成交额473.31万	换手率2.65%	流通股本5,301万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRME","market":"US","secType":"STK","nameCN":"Prime Medicine, Inc.","latestPrice":3.345,"timestamp":1731704400000,"preClose":3.595,"halted":0,"volume":1402038,"hourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.345,"latestTime":"19:41 EST","volume":8459,"amount":28480.816,"timestamp":1731717661957},"delay":0,"floatShares":53006500,"shares":127595580,"eps":-2.131794,"marketStatus":"休市中","marketStatusCode":7,"change":-0.25,"latestTime":"11-15 16:00:00 EST","open":3.61,"high":3.61,"low":3.3001,"amount":4733122.418521199,"amplitude":0.086203,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.131794,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1666238400000,"adjPreClose":3.595,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.6197,"preClose":3.595,"latestTime":"09:27 EST","volume":1849,"amount":6692.9830197,"timestamp":1731680872539},"postHourTrading":{"tag":"盘后","latestPrice":3.4,"preClose":3.345,"latestTime":"19:41 EST","volume":8459,"amount":28480.816,"timestamp":1731717661957},"volumeRatio":0.9736056984252359,"impliedVol":2.1845,"impliedVolPercentile":0.869},"requestUrl":"/m/hq/s/PRME/tweets","defaultTab":"tweets","newsList":[{"id":"2483370037","title":"Prime Medicine, Inc.盘中异动 早盘股价大跌5.01%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483370037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483370037?lang=zh_cn&edition=full","pubTime":"2024-11-15 23:05","pubTimestamp":1731683115,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日23时05分，Prime Medicine, Inc.股票出现波动，股价快速跳水5.01%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为2.62%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115230516971a6de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115230516971a6de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2483180444","title":"Prime Medicine, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483180444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483180444?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:42","pubTimestamp":1731595371,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时42分，Prime Medicine, Inc.股票出现异动，股价快速下跌5.30%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224251abc160cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114224251abc160cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2482382437","title":"Prime Medicine, Inc.盘中异动 大幅上涨5.12%报4.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482382437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482382437?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:39","pubTimestamp":1731335956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时39分，Prime Medicine, Inc.股票出现波动，股价快速上涨5.12%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223916971a5b43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223916971a5b43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2481321637","title":"Prime Medicine, Inc.盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481321637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481321637?lang=zh_cn&edition=full","pubTime":"2024-11-06 03:26","pubTimestamp":1730834785,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日03时26分，Prime Medicine, Inc.股票出现波动，股价急速拉升5.05%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.54%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110603262598e409ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110603262598e409ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2479031853","title":"Prime Medicine, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479031853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479031853?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:29","pubTimestamp":1730384985,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时29分，Prime Medicine, Inc.股票出现异动，股价大幅下跌5.16%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为2.83%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031222945971a392f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031222945971a392f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2479870922","title":"Prime Medicine, Inc.盘中异动 大幅下跌5.23%报3.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479870922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479870922?lang=zh_cn&edition=full","pubTime":"2024-10-29 23:09","pubTimestamp":1730214548,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日23时09分，Prime Medicine, Inc.股票出现异动，股价快速下挫5.23%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029230908a1f5e572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029230908a1f5e572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2478966426","title":"Prime Medicine, Inc.盘中异动 急速上涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478966426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478966426?lang=zh_cn&edition=full","pubTime":"2024-10-25 02:46","pubTimestamp":1729795599,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日02时46分，Prime Medicine, Inc.股票出现波动，股价大幅上涨5.39%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025024639971a2213&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025024639971a2213&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2477453546","title":"Prime Medicine, Inc.盘中异动 急速跳水5.06%报4.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477453546","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477453546?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:03","pubTimestamp":1729692230,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日22时03分，Prime Medicine, Inc.股票出现异动，股价急速下跌5.06%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为1.38%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220350ab6d80be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023220350ab6d80be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2477729356","title":"Prime Medicine, Inc.盘中异动 早盘急速下跌5.03%报4.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477729356","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477729356?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:56","pubTimestamp":1729608999,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时56分，Prime Medicine, Inc.股票出现波动，股价急速跳水5.03%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022225640a1e2d3c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022225640a1e2d3c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2477864563","title":"Prime Medicine, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477864563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477864563?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:35","pubTimestamp":1729521301,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时35分，Prime Medicine, Inc.股票出现异动，股价大幅下跌5.01%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021223502a1e24ce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021223502a1e24ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2476823019","title":"Prime Medicine, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476823019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476823019?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:33","pubTimestamp":1729258425,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时33分，Prime Medicine, Inc.股票出现波动，股价大幅上涨5.26%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213345971a11d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213345971a11d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2476795751","title":"Prime Medicine, Inc.盘中异动 急速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476795751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476795751?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:16","pubTimestamp":1729174600,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时16分，Prime Medicine, Inc.股票出现波动，股价大幅跳水5.02%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221640971a0dbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017221640971a0dbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2475135929","title":"Prime Medicine, Inc.盘中异动 大幅上涨5.31%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475135929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475135929?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:07","pubTimestamp":1729087621,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时07分，Prime Medicine, Inc.股票出现波动，股价大幅拉升5.31%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016220701ab6a8ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016220701ab6a8ff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2474627700","title":"Prime Medicine, Inc.盘中异动 下午盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474627700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474627700?lang=zh_cn&edition=full","pubTime":"2024-10-10 02:16","pubTimestamp":1728497810,"startTime":"0","endTime":"0","summary":"北京时间2024年10月10日02时16分，Prime Medicine, Inc.股票出现异动，股价大幅下跌5.03%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010021650ab68e5ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010021650ab68e5ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2473481373","title":"Prime Medicine, Inc.盘中异动 下午盘急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473481373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473481373?lang=zh_cn&edition=full","pubTime":"2024-10-08 01:37","pubTimestamp":1728322679,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日01时37分，Prime Medicine, Inc.股票出现波动，股价快速拉升5.10%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100801375998e3ae81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100801375998e3ae81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2472952106","title":"Prime Medicine, Inc.盘中异动 股价大涨6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952106","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952106?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:31","pubTimestamp":1728048684,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时31分，Prime Medicine, Inc.股票出现异动，股价大幅拉升6.16%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。消息层面，截至21时31分，《百时美施贵宝与Prime Medicine合作开发创新细胞疗法》资讯为影响Prime Medicine, Inc.的重要信息。根据协议，Prime Medicine将对选定的特定靶点设计优化的Prime Editor，并使用其PASSIGE技术平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042131249719e5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410042131249719e5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2472840396","title":"百时美施贵宝(BMY.US)与Prime Medicine(PRME.US)合作开发创新细胞疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2472840396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472840396?lang=zh_cn&edition=full","pubTime":"2024-10-03 08:09","pubTimestamp":1727914147,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月30日，Prime Medicine宣布与施贵宝达成战略研发合作和授权协议，共同开发下一代T细胞疗法。这一合作将结合Prime Medicine精准的多重基因编辑能力，及施贵宝在开发和商业化创新细胞疗法方面的专长。根据协议，Prime Medicine将对选定的特定靶点设计优化的Prime Editor，并使用其PASSIGE技术平台。Prime Medicine的技术将Prime Editing与整合酶或其他位点特异性重组酶相结合，将大基因货物引入基因组，以实现稳定的货物表达。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1189870.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2125154778.USD","LU0985481810.HKD","IE0009355771.USD","LU0456855351.SGD","LU1989771016.USD","LU0225771236.USD","BK4588","LU0868494617.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1261432733.SGD","BMY","LU1074936037.SGD","LU1032466523.USD","LU2360032135.SGD","LU2133065610.SGD","BK4581","LU1585245621.USD","IE00B2B36J28.USD","LU1291159041.SGD","LU1093756325.SGD","LU1670711040.USD","LU2242652126.USD","BK4007","BK4532","LU2242646821.SGD","LU0306807586.USD","BK4534","LU0225284248.USD","LU0237698245.USD","LU1430594728.SGD","LU1093756168.USD","IE0002141913.USD","LU1571399168.USD","LU1670710661.SGD","LU1670711123.USD","LU2125154935.USD","PRME","LU1718418525.SGD","LU0061475181.USD","BK4139","BK4585","BK4559","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU1670710588.SGD","LU0321505868.SGD","LU0882574055.USD","LU0321505439.SGD","LU0114720955.EUR"],"gpt_icon":0},{"id":"2472765683","title":"Prime Medicine, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472765683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472765683?lang=zh_cn&edition=full","pubTime":"2024-10-01 21:40","pubTimestamp":1727790004,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日21时40分，Prime Medicine, Inc.股票出现异动，股价快速下跌5.17%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214005ab675020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001214005ab675020&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"1142661554","title":"Prime Medicine盘中大涨45%，与施贵宝签署合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1142661554","media":"老虎资讯综合","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142661554?lang=zh_cn&edition=full","pubTime":"2024-09-30 23:19","pubTimestamp":1727709577,"startTime":"0","endTime":"0","summary":"双方同意共同开发和商业化多种疗法。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Prime Medicine与施贵宝达成合作，后者将投资5500万美元购买Prime股权","news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2471382605","title":"BUZZ-由于获得百时美施贵宝的投资和许可协议，Prime Medicine 将迎来有史以来最好的一天","url":"https://stock-news.laohu8.com/highlight/detail?id=2471382605","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471382605?lang=zh_cn&edition=full","pubTime":"2024-09-30 22:55","pubTimestamp":1727708130,"startTime":"0","endTime":"0","summary":"BUZZ-由于获得百时美施贵宝的投资和许可协议，Prime Medicine 将迎来有史以来最好的一天更新9月30日 -  ** Prime Medicine PRME.O股价大涨31.5%至4.55美元，如果涨势得以保持，将创下历史最好水平。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240930:nL4S3LC1AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","BMY","LU1585245621.USD","LU2133065610.SGD","BK4588","IE00BJJMRZ35.SGD","BK4532","LU1571399168.USD","LU1670710661.SGD","IE0009355771.USD","LU1291159041.SGD","IE00BSNM7G36.USD","BK4585","LU2125154778.USD","LU2125154935.USD","LU1032466523.USD","LU1074936037.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0237698245.USD","LU0225284248.USD","LU0321505439.SGD","LU0225771236.USD","LU0321505868.SGD","BK4534","LU1670710588.SGD","LU1670711040.USD","BK4007","IE00BFTCPJ56.SGD","LU0114720955.EUR","PRME","LU0882574055.USD","LU1670711123.USD","BK4581","LU0061475181.USD","LU1989771016.USD","LU1093756168.USD","IE0002141913.USD","LU0868494617.USD","LU1718418525.SGD","LU2242652126.USD","LU1261432733.SGD","LU0306807586.USD","LU1430594728.SGD","IE00B2B36J28.USD","LU0306806265.USD","LU0985481810.HKD","LU2360032135.SGD","BK4139","LU2242646821.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.primemedicine.com","stockEarnings":[{"period":"1week","weight":-0.1841},{"period":"1month","weight":-0.1553},{"period":"3month","weight":-0.2111},{"period":"6month","weight":-0.5275},{"period":"1year","weight":-0.4561},{"period":"ytd","weight":-0.6225}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prime Medicine, Inc.于2019年9月在特拉华州注册成立。他们是一家生物技术公司，致力于提供一类新的差异化一次性治愈性基因疗法Prime Editors，通过部署Prime Editing解决最广泛的疾病技术。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.013349},{"month":2,"riseRate":0.75,"avgChangeRate":-0.006023},{"month":3,"riseRate":0.75,"avgChangeRate":0.02763},{"month":4,"riseRate":0.5,"avgChangeRate":0.010576},{"month":5,"riseRate":1,"avgChangeRate":0.002703},{"month":6,"riseRate":0.5,"avgChangeRate":0.004716},{"month":7,"riseRate":0.75,"avgChangeRate":0.014069},{"month":8,"riseRate":0.25,"avgChangeRate":0.010977},{"month":9,"riseRate":0,"avgChangeRate":-0.015899},{"month":10,"riseRate":0.25,"avgChangeRate":-0.030391},{"month":11,"riseRate":0.666667,"avgChangeRate":0.001019},{"month":12,"riseRate":0.5,"avgChangeRate":-0.025302}],"exchange":"NASDAQ","name":"Prime Medicine, Inc.","nameEN":"Prime Medicine, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prime Medicine, Inc.(PRME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prime Medicine, Inc.,PRME,Prime Medicine, Inc.股票,Prime Medicine, Inc.股票老虎,Prime Medicine, Inc.股票老虎国际,Prime Medicine, Inc.行情,Prime Medicine, Inc.股票行情,Prime Medicine, Inc.股价,Prime Medicine, Inc.股市,Prime Medicine, Inc.股票价格,Prime Medicine, Inc.股票交易,Prime Medicine, Inc.股票购买,Prime Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prime Medicine, Inc.(PRME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}